Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera Reports Interim Results On Convertible Bond Exchange Offer

April 20 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * SANTHERA REPORTS INTERIM RESULTS ON CONVERTIBLE BOND
EXCHANGE
OFFER
    * SO FAR AN AGGREGATE PRINCIPAL VALUE OF AROUND CHF 39.6
MILLION,
OR 66% OF ITS CHF 60 MILLION CONVERTIBLE BONDS, HAVE BEEN
ACCEPTED FOR EXCHANGE UNDER EXCHANGE OFFER ANNOUNCED ON MARCH
25, 2021
    * BONDHOLDERS WHO HAVE NOT YET ACCEPTED EXCHANGE OFFER WILL
BE
ABLE TO DO SO DURING ADDITIONAL ACCEPTANCE PERIOD ENDING ON
APRIL 27, 2021, 5:00 P.M
    * BONDHOLDERS HAVE ACCEPTED EXCHANGE OFFER WITH RESPECT TO
2017/22
BONDS WITH AN AGGREGATE PRINCIPAL AMOUNT OF CHF 39,620,000,
CORRESPONDING TO 66.03% OF ALL 2017/22 BONDS IN CIRCULATION

Source text for Eikon:  ID:nGNE15Fzy6 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news